Autoimmune disease drugs

These companies develop drugs that calm the immune system in diseases like lupus, rheumatoid arthritis and vasculitis.
+37.9%
over 6 months · S&P 500 +2.6%

Key indicators

Health
50 / 100
Fragile
Solid
Price
P/E 25
Cheap
Expensive
Up over 1 year
30 of 46
Wallets over 90 days
1 / 2 buys / sells
Buys
Sells
Health and price: against the other tags.

The 52 companies

LLY
+43.8%
JNJ
+27.4%
ABBV
+41.2%
Size: weight in the tag. Color: move over the period.
See all companies
L
Eli Lilly
LLY
51.6%
+43.8%
J
Johnson & Johnson
JNJ
25.5%
+27.4%
A
AbbVie
ABBV
20.0%
+41.2%
K
Kymera Therapeutics
KYMR
0.4%
+55.2%
S
Spyre Therapeutics
SYRE
0.4%
+38.8%
T
TG Therapeutics
TGTX
0.4%
+63.3%
I
Immunovant
IMVT
0.3%
+24.3%
O
Oruka Therapeutics
ORKA
0.3%
+70.1%
D
Dianthus Therapeutics
DNTH
0.2%
+6.6%
V
Viridian Therapeutics
VRDN
0.1%
+83.5%
X
Xencor
XNCR
0.1%
+230.6%
C
Celldex Therapeutics
CLDX
<0.1%
−8.0%
T
First Tracks Biotherapeutics
TRAX
<0.1%
+178.7%
Z
Zenas BioPharma
ZBIO
<0.1%
+52.7%
N
Nektar Therapeutics
NKTR
<0.1%
−47.2%
V
Vor Biopharma
VOR
<0.1%
+32.7%
J
Jade Biosciences
JBIO
<0.1%
−30.9%
O
Odyssey Therapeutics
ODTX
<0.1%
+8.6%
C
Corvus Pharmaceuticals
CRVS
<0.1%
−13.6%
G
Monte Rosa Therapeutics
GLUE
<0.1%
−48.4%
A
Alumis
ALMS
<0.1%
−75.5%
C
Cullinan Therapeutics
CGEM
<0.1%
−34.6%
A
Attovia Therapeutics
ATTO
<0.1%
C
Climb Bio
CLYM
<0.1%
−4.1%
A
Aclaris Therapeutics
ACRS
<0.1%
−13.3%
S
Shattuck Labs
STTK
<0.1%
−25.7%
A
Avalo Therapeutics
AVTX
<0.1%
−56.3%
C
Cabaletta Bio
CABA
<0.1%
−61.3%
E
Enanta Pharmaceuticals
ENTA
<0.1%
−18.0%
K
Kyverna Therapeutics
KYTX
<0.1%
−46.8%
E
Evommune
EVMN
<0.1%
−66.7%
Q
Q32 Bio
QTTB
<0.1%
+38.3%
A
Artiva Biotherapeutics
ARTV
<0.1%
−59.0%
P
Palisade Bio
PALI
<0.1%
−38.8%
Y
Yarrow Bioscience
YARW
<0.1%
−2.0%
F
Fate Therapeutics
FATE
<0.1%
−27.1%
Z
Zura Bio
ZURA
<0.1%
−73.7%
C
Cue Biopharma
CUE
<0.1%
−29.9%
A
Adicet Bio
ACET
<0.1%
−63.8%
A
Abivax
ABVX
−23.5%
A
argenx
ARGX
+20.1%
A
Aurinia Pharmaceuticals
AUPH
+2.9%
A
Autolus Therapeutics
AUTL
−28.2%
B
Bambusa Therapeutics
BBTX
E
Electra Therapeutics
ETRA
L
Lakefront Biotherapeutics
LKFT
+25.6%
L
Lycia Therapeutics
LYCA
M
Mesoblast
MESO
−11.5%
M
MoonLake Immunotherapeutics
MLTX
−28.8%
N
Novartis
NVS
+8.4%
R
Roche Holdings
RHHBY
0.0%
R
Roivant Sciences
ROIV
+35.0%